A new study has explored changes to the gut microbiome in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The study’s unique design shows the long-term effects of ME/CFS and identifies a group of microbes associated with the disease’s pathology.
The microbiome and ME/CFS
ME/CFS is a disabling illness that is thought to affect up to 2.5 million Americans, although 9 in 10 remain undiagnosed. The condition produces a range of functional impairments and cognitive symptoms, including overwhelming fatigue, sleep disruption, difficulty concentrating, dizziness and pain. The disease, long overlooked by medical authorities, has been increasingly recognized due to its similarities to the effects of long-COVID. Research into possible links to viral infection and the role of the immune system in the disease’s pathology has ramped up.